Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeObject Symbol | Species | Term | Qualifier | Evidence | With | Notes | Source | Original Reference(s) | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | abnormal response of heart to induced stress | susceptibility | IAGP | cold ambient air exposure and guanethidine | compared to WKY/Izm | RGD | | Cstrr1 | Rat | abnormal sensory capabilities/reflexes/nociception | | IAGP | | | RGD | | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | abnormal sensory capabilities/reflexes/nociception | susceptibility | IAGP | cold ambient air exposure | compared to WKY/Izm | RGD | | WKY/Izm | Rat | decreased urine adrenaline level | susceptibility | IAGP | | compared to SHRSP/Izm | RGD | | WKY/Izm | Rat | decreased urine dopamine level | susceptibility | IAGP | | compared to SHRSP/Izm | RGD | | WKY/Izm | Rat | decreased urine noradrenaline level | susceptibility | IAGP | | compared to SHRSP/Izm | RGD | | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | hypertension | susceptibility | IAGP | cold ambient air exposure | compared to WKY/Izm | RGD | | Cstrr1 | Rat | increased circulating noradrenaline level | | IAGP | | | RGD | | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | increased circulating noradrenaline level | susceptibility | IAGP | | compared to WKY/Izm | RGD | | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | increased heart weight | susceptibility | IAGP | | compared to WKY/Izm | RGD | | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | increased kidney weight | susceptibility | IAGP | | compared to WKY/Izm | RGD | | Cstrr1 | Rat | increased systemic arterial blood pressure | | IAGP | | | RGD | | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | increased systemic arterial blood pressure | susceptibility | IAGP | | compared to WKY/Izm | RGD | | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | increased systemic arterial diastolic blood pressure | susceptibility | IAGP | | compared to WKY/Izm | RGD | | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | increased systemic arterial systolic blood pressure | susceptibility | IAGP | | compared to WKY/Izm | RGD | | SHRSP/Izm | Rat | increased urine adrenaline level | susceptibility | IAGP | cold ambient air exposure | compared to WKY/Izm | RGD | | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | increased urine adrenaline level | susceptibility | IAGP | | compared to WKY/Izm | RGD | | SHRSP/Izm | Rat | increased urine dopamine level | susceptibility | IAGP | cold ambient air exposure | compared to WKY/Izm | RGD | | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | increased urine dopamine level | susceptibility | IAGP | | compared to WKY/Izm | RGD | | SHRSP/Izm | Rat | increased urine noradrenaline level | susceptibility | IAGP | cold ambient air exposure | compared to WKY/Izm | RGD | | WKY.SHRSP-(D1Wox29-D1Arb21)/Izm | Rat | increased urine noradrenaline level | susceptibility | IAGP | | compared to WKY/Izm | RGD | | |